Hu cancer treatment theory and laws 5
•Download as PPTX, PDF•
0 likes•33 views
Cancer is a complex disease caused by both internal and external factors that damage genes. While modern medicine has made progress against some cancers, treatment outcomes remain poor for many. A balanced, multi-disciplinary approach considering mind, body and spirit may help address underlying causes and vulnerabilities to achieve holistic health.
Report
Share
Report
Share
Recommended
Oncology and Ocosurgery
Oncology is that department of medicine that deals with tumors. A medical professional who practices oncology is an oncologist.This includes the detection of any cancer in person , therapies, post care of cancer patients after treatments in the superspeciality hospitals
The Effect of Deep Oscillation in Fibrocystic Breast Disease. A Randomized C...
A randomized controlled trial of 401 women randomly assigned to three groups has come to remarkable conclusions: treatment with deep oscillation not only reduced the patients' pain perception statistically significantly; above all, it reduces the proportion of fibrosed and cystic tissue, both in comparison to a control group treated with a non-steroidal anti-inflammatory drug (NSAID) and a control group without intervention. The research group led by Solangel Hernández Tápanes concludes that Deep Oscillation favors the absorption of fibrosed and cystic tissue due to its tissue relaxant and vasoconstrictor action.
The study was published in the current issue Vol. 11, no. 14 of the Open Access Journal "International Archives of Medicine"
Early and locally advanced breast cancer
This document discusses the management of early and locally advanced breast cancer. For early breast cancer, primary surgery involves lumpectomy or mastectomy followed by adjuvant treatment if needed based on tumor characteristics. Breast conserving surgery aims to preserve the breast while achieving comparable survival to mastectomy with low recurrence rates. Neoadjuvant therapy can help reduce tumor size for breast conservation. Locally advanced breast cancer may be treated with neoadjuvant chemotherapy to reduce the risk of recurrence and improve surgical outcomes. Neoadjuvant endocrine therapy is also an option for some postmenopausal women. Adjuvant radiation, chemotherapy, and hormone therapy are used based on tumor markers and response to neoadjuvant treatment. Regular
Current Operative Management of Early Breast Cancer
The document provides an outline on the current operative management of early breast cancer. It discusses the historical perspectives, definitions, considerations, landmark trials, diagnostic techniques, staging, neoadjuvant treatment, management of stage 0 disease, axillary management guidelines, operative options including oncoplastic breast-conserving surgery and reconstructive options, adjuvant therapy, prognosis, and follow-up. The document aims to provide guidance on achieving cure while preserving aesthetics in the treatment of early breast cancer.
Early breast cancer
This document discusses various aspects of managing early stage breast cancer, including:
1. It provides an overview of the evolution of surgical approaches from radical to breast conserving surgery and discusses key trials demonstrating equivalent survival with breast conservation plus radiation compared to mastectomy.
2. It discusses the changing approach to axillary staging from axillary dissection to sentinel lymph node biopsy and trials validating the adequacy of sentinel node biopsy alone in certain cases.
3. It addresses locoregional treatment approaches including the appropriate use of radiation after lumpectomy, mastectomy, and with varying nodal involvement based on guidelines.
2021 book atlas_ofminimallyinvasiveandrob
This chapter provides an overview of minimally invasive and robotic esophagectomy. Esophagectomy is a challenging surgery for esophageal cancer with historical perioperative mortality rates of 3-4% and major morbidity rates of 30-40% with open techniques. The adoption of minimally invasive approaches, both hybrid and fully endoscopic, has led to reductions in postoperative pulmonary complications, blood loss, hospital stay, and improved quality of life compared to open surgery, without compromising oncologic outcomes. Further improvements have been seen with robotic-assisted minimally invasive esophagectomy compared to open surgery as well. Ongoing studies continue to evaluate outcomes as these newer techniques diffuse more widely.
Rx of mammaoccult cancer
Breast Conservation in the Setting of Contemporary
Multimodality Treatment Provides Excellent Outcomes
for Patients with Occult Primary Breast Cancer
Efruzhu cancer carcinogenesis theory13
Cancer cell growth and development involves dual-binary mechanisms and dynamics that have a dependent relationship on dual-binary identity. All the mechanisms and actions of cancer cell formation have a two-part, binary nature that is reliant on a dualistic, two-state existence.
Recommended
Oncology and Ocosurgery
Oncology is that department of medicine that deals with tumors. A medical professional who practices oncology is an oncologist.This includes the detection of any cancer in person , therapies, post care of cancer patients after treatments in the superspeciality hospitals
The Effect of Deep Oscillation in Fibrocystic Breast Disease. A Randomized C...
A randomized controlled trial of 401 women randomly assigned to three groups has come to remarkable conclusions: treatment with deep oscillation not only reduced the patients' pain perception statistically significantly; above all, it reduces the proportion of fibrosed and cystic tissue, both in comparison to a control group treated with a non-steroidal anti-inflammatory drug (NSAID) and a control group without intervention. The research group led by Solangel Hernández Tápanes concludes that Deep Oscillation favors the absorption of fibrosed and cystic tissue due to its tissue relaxant and vasoconstrictor action.
The study was published in the current issue Vol. 11, no. 14 of the Open Access Journal "International Archives of Medicine"
Early and locally advanced breast cancer
This document discusses the management of early and locally advanced breast cancer. For early breast cancer, primary surgery involves lumpectomy or mastectomy followed by adjuvant treatment if needed based on tumor characteristics. Breast conserving surgery aims to preserve the breast while achieving comparable survival to mastectomy with low recurrence rates. Neoadjuvant therapy can help reduce tumor size for breast conservation. Locally advanced breast cancer may be treated with neoadjuvant chemotherapy to reduce the risk of recurrence and improve surgical outcomes. Neoadjuvant endocrine therapy is also an option for some postmenopausal women. Adjuvant radiation, chemotherapy, and hormone therapy are used based on tumor markers and response to neoadjuvant treatment. Regular
Current Operative Management of Early Breast Cancer
The document provides an outline on the current operative management of early breast cancer. It discusses the historical perspectives, definitions, considerations, landmark trials, diagnostic techniques, staging, neoadjuvant treatment, management of stage 0 disease, axillary management guidelines, operative options including oncoplastic breast-conserving surgery and reconstructive options, adjuvant therapy, prognosis, and follow-up. The document aims to provide guidance on achieving cure while preserving aesthetics in the treatment of early breast cancer.
Early breast cancer
This document discusses various aspects of managing early stage breast cancer, including:
1. It provides an overview of the evolution of surgical approaches from radical to breast conserving surgery and discusses key trials demonstrating equivalent survival with breast conservation plus radiation compared to mastectomy.
2. It discusses the changing approach to axillary staging from axillary dissection to sentinel lymph node biopsy and trials validating the adequacy of sentinel node biopsy alone in certain cases.
3. It addresses locoregional treatment approaches including the appropriate use of radiation after lumpectomy, mastectomy, and with varying nodal involvement based on guidelines.
2021 book atlas_ofminimallyinvasiveandrob
This chapter provides an overview of minimally invasive and robotic esophagectomy. Esophagectomy is a challenging surgery for esophageal cancer with historical perioperative mortality rates of 3-4% and major morbidity rates of 30-40% with open techniques. The adoption of minimally invasive approaches, both hybrid and fully endoscopic, has led to reductions in postoperative pulmonary complications, blood loss, hospital stay, and improved quality of life compared to open surgery, without compromising oncologic outcomes. Further improvements have been seen with robotic-assisted minimally invasive esophagectomy compared to open surgery as well. Ongoing studies continue to evaluate outcomes as these newer techniques diffuse more widely.
Rx of mammaoccult cancer
Breast Conservation in the Setting of Contemporary
Multimodality Treatment Provides Excellent Outcomes
for Patients with Occult Primary Breast Cancer
Efruzhu cancer carcinogenesis theory13
Cancer cell growth and development involves dual-binary mechanisms and dynamics that have a dependent relationship on dual-binary identity. All the mechanisms and actions of cancer cell formation have a two-part, binary nature that is reliant on a dualistic, two-state existence.
Primary Systemic Therapy for Inflammatory Breast Cancer
1) Primary systemic therapy with chemotherapy is used to begin treatment for inflammatory breast cancer (IBC) since it is inoperable at diagnosis.
2) IBC has been shown to be relatively chemoresistant, so identifying targeted therapeutic approaches is important.
3) Clinical trials specifically designed for IBC are needed, as including IBC patients in locally advanced breast cancer trials makes it difficult to interpret outcomes for IBC. Such trials should incorporate translational components to further understand IBC biology.
Management of axilla in carcinoma breast
This document provides an overview of the management of the axilla in breast cancer. It discusses the anatomy and lymphatic drainage of the breast and axilla. It covers staging of the axilla including physical exam, ultrasound, and surgical staging with sentinel lymph node biopsy or axillary lymph node dissection. It discusses treatment approaches for node-negative and node-positive disease, including controversies around isolated tumor cells and micrometastases. It also addresses special populations like elderly patients and those receiving neoadjuvant chemotherapy. Complications of axillary lymph node dissection are reviewed as well as techniques to reduce morbidity. The role of radiotherapy in the axilla is briefly mentioned.
Surgeon-Anaesthetist-Intensivist Crosstalk In Abdominal Emergencies (Zsolt Bo...
“One man never made a team.”
Detailed and well-structured handover from operating theatre to ICU is a cornerstone for uncomplicated postoperative care. The constant handover of the information between the members of the perioperative team (surgeon+anaesthetist+intensivist) is a crucial importance. Surgeon and anaesthetist are the key players in the operating room, aiming for a common goal – safety and good outcome for patient. Communication is the glue that holds the team together and is the source of motivation for all and the followings always should been discussed (Reintam et al.):
- exact description of surgical procedure (type of resection, number and placement of drains, timing of drain removal, etc...)
- possible bowel distention and impaired perfusion
- contamination of peritoneal cavity
- location of anastomosis, stoma (small bowel or colon), quality of anastomosis
- risk for bleeding
- type of closure (mesh, fascial, open abdomen, etc...)
- when to start oral diet / enteral feeding
Sentinel node and PET for local advanced breast cancer
To validate sentinel node biopsy (SLN) for patients with complete axillary response to preoperative chemotherapy
Advanced breast cancer & chemo by me
This document summarizes the presentation of Dr. Sadia Sadiq on locally advanced breast cancer and chemotherapy. The presentation covers staging of breast cancer, local surgical treatments, management of the axilla, adjuvant and neoadjuvant chemotherapy. It discusses the evolution of surgical treatments from radical mastectomy to breast-conserving surgery plus radiation. It also summarizes landmark trials comparing different chemotherapy regimens and the addition of taxanes to anthracycline-based regimens. Finally, it notes that sequential therapy with anthracyclines/alkylators followed by taxanes was proven superior to concurrent taxane-anthracycline-alkylator treatments.
Early breast cancer management
This document discusses the management of early breast cancer. It covers breast management including breast-conserving surgery and mastectomy. It discusses axillary management including axillary lymph node dissection and sentinel lymph node biopsy. It also discusses the roles of pre-operative systemic therapy, adjuvant therapy including anti-HER2 therapy, chemotherapy, and hormonal therapy based on breast cancer subtypes. The document provides guidelines on treatment options based on breast cancer stage and molecular profiles.
Early Stage Breast Cancer and Radiation Therapy
These slides are intended as an educational overview for newly diagnosed early stage breast cancer patients. My hope is that it can complement and enhance the doctor-patient relationship and shared decision making. I welcome any feedback on how to improve it.
Radiotherapy breast
The document discusses breast-conserving treatment for early-stage breast cancer. Breast-conserving treatment, including wide local excision of the tumor, axillary lymph node dissection, and breast irradiation, is now the standard of care for most women with early-stage invasive breast cancer. Ideal candidates for breast-conserving treatment have unicentric primary tumors less than 4-5 cm in diameter. Contraindications include positive margins, advanced or multicentric disease, pregnancy, and prior radiation. The addition of a radiation boost to the tumor bed after whole breast irradiation reduces the risk of local recurrence. Hypofractionated regimens have been shown to be as effective as conventional fractionation with shorter treatment times.
Efruzhu cancer carcinogenesis theory20
Decreasing energy levels in cells can cause an increase in mutations, leading to higher malignancy and aggressiveness of cancer. Lower energy levels may promote more mutations that drive carcinogenesis. Cells with decreased energy and more mutations are likely to become more malignant tumors.
Efruzhu cancer carci̇nogenesi̇s theory20
This document discusses a theory that decreasing energy levels or degrees within cells can cause an increase in mutations, leading to higher levels of malignancy and aggressiveness in cancer. Specifically, the theory proposes that as energy decreases within cells, mutation rates rise, resulting in more malignant and aggressive forms of cancer.
Locally advanced breast cancer
This document discusses the management of locally advanced breast cancer (LABC). Key points:
1. LABC includes stages IIIA, IIIB, IIIC breast cancer with large tumors (>5cm), chest wall involvement, skin ulcers, or fixed lymph nodes. Inflammatory breast cancer is an aggressive subtype of LABC.
2. Diagnosis involves history, physical exam, imaging like mammography and MRI, and biopsy. Staging workup includes labs, imaging of chest, abdomen, pelvis and bone.
3. Treatment involves neoadjuvant chemotherapy to downstage the cancer and allow for surgery. Surgery may include mastectomy or breast conservation. Postoperative radiation and endocrine therapy
MCO 2011 - Slide 8 - E. Senkus-Konefka - Treatment of metastatic disease and ...
MCO 2011 - Slide 8 - E. Senkus-Konefka - Treatment of metastatic disease and ...European School of Oncology
(1) Neoadjuvant therapy for breast cancer can improve operability and allow for breast-conserving surgery, though some studies have found higher recurrence rates in patients who undergo less aggressive local therapy after tumor shrinkage from neoadjuvant treatment.
(2) The NOAH study found that adding trastuzumab to neoadjuvant chemotherapy significantly improved pathological complete response rates and event-free survival in HER2-positive breast cancer compared to chemotherapy alone.
(3) Multiple studies have found a survival benefit for surgery in selected metastatic breast cancer patients, such as those with a solitary metastasis or intact primary tumor, suggesting a more aggressive multidisciplinary approach may be warranted in these cases.BALKAN MCO 2011 - E. Vrdoljak - Locoregional therapy in LABC
The document discusses evidence from randomized controlled trials on the use of postmastectomy radiotherapy (PMRT) for breast cancer patients. The key trials found that PMRT reduces locoregional recurrence rates from 30% to 10% and breast cancer mortality by 5% at 15 years. PMRT improved disease-free and overall survival rates particularly in patients with 4 or more positive lymph nodes. Modern radiotherapy techniques can help reduce risks of complications from PMRT.
BALKAN MCO 2011 - A. Eniu - How to optimize systemic therapy in LABC
This document discusses treatment options for locally advanced breast cancer (LABC). It notes that LABC is a heterogeneous disease and standard primary chemotherapy includes anthracyclines and taxanes. Neoadjuvant chemotherapy is now the standard of care as it allows for breast conservation in some cases and those who achieve a pathological complete response have improved survival rates. The response to neoadjuvant therapy and molecular subtypes (e.g. triple negative, HER2-positive) can help determine the most effective adjuvant treatment strategy. Targeted therapies like trastuzumab improve outcomes for HER2-positive breast cancer when given with chemotherapy in the neoadjuvant setting.
Artículo sobre la mejora del hábitat del oso pardo en el Alto Sil de León
La población de oso pardo en la Cordillera Cantábrica se ha multiplicado por tres en los últimos quince años, con alrededor de 180 osos en la subpoblación occidental y 30 en la oriental. Aunque la recuperación de la subpoblación oriental ha sido más lenta, se cree que el proceso es ahora imparable. La Fundación Banco Santander plantará 18.000 frutales en zonas mineras de León para proporcionar refugio y alimento a los osos y ayudar a unir las dos subpoblaciones.
1 pager of on demand resources
This document provides a list of useful resources for Connect hosts, including quick start guides, user manuals, daily online training, on-demand video tutorials, resource centers, user forums, webinars, downloads, and information on custom apps and extensions.
Untitled Presentation
The document is a Haiku Deck presentation that contains photos credited to four different photographers and encourages the viewer to create their own Haiku Deck presentation on SlideShare.
#BMO15 | Altrove | Niccolò Falsetti
#Altrove (www.altrove.me) è un esperimento che si presenta sotto forma di gioco urbano. I protagonisti, i giocatori, sono dieci ragazzi che attraversano la città e il web non come luoghi da cui fuggire ma come situazioni da esplorare. Lo ha raccontato come un “real life-social network”. Niccolò Falsetti (nato a Grosseto classe 1987) è uno degli ideatori del progetto Altrove.
Cronica tita
El documento describe el programa TIT@ Educación Digital para Todos implementado por el Ministerio de Educación y la Universidad del Valle en Colombia. El programa busca capacitar maestros en el uso de las TIC en la enseñanza mediante cinco momentos que incluyen contextualización, adaptación, adopción, apropiación y transformación del aprendizaje. La autora del documento detalla su experiencia participando en el programa, en el que ha adquirido nuevas habilidades y herramientas que le han permitido enriquecer su práctica docente.
More Related Content
What's hot
Primary Systemic Therapy for Inflammatory Breast Cancer
1) Primary systemic therapy with chemotherapy is used to begin treatment for inflammatory breast cancer (IBC) since it is inoperable at diagnosis.
2) IBC has been shown to be relatively chemoresistant, so identifying targeted therapeutic approaches is important.
3) Clinical trials specifically designed for IBC are needed, as including IBC patients in locally advanced breast cancer trials makes it difficult to interpret outcomes for IBC. Such trials should incorporate translational components to further understand IBC biology.
Management of axilla in carcinoma breast
This document provides an overview of the management of the axilla in breast cancer. It discusses the anatomy and lymphatic drainage of the breast and axilla. It covers staging of the axilla including physical exam, ultrasound, and surgical staging with sentinel lymph node biopsy or axillary lymph node dissection. It discusses treatment approaches for node-negative and node-positive disease, including controversies around isolated tumor cells and micrometastases. It also addresses special populations like elderly patients and those receiving neoadjuvant chemotherapy. Complications of axillary lymph node dissection are reviewed as well as techniques to reduce morbidity. The role of radiotherapy in the axilla is briefly mentioned.
Surgeon-Anaesthetist-Intensivist Crosstalk In Abdominal Emergencies (Zsolt Bo...
“One man never made a team.”
Detailed and well-structured handover from operating theatre to ICU is a cornerstone for uncomplicated postoperative care. The constant handover of the information between the members of the perioperative team (surgeon+anaesthetist+intensivist) is a crucial importance. Surgeon and anaesthetist are the key players in the operating room, aiming for a common goal – safety and good outcome for patient. Communication is the glue that holds the team together and is the source of motivation for all and the followings always should been discussed (Reintam et al.):
- exact description of surgical procedure (type of resection, number and placement of drains, timing of drain removal, etc...)
- possible bowel distention and impaired perfusion
- contamination of peritoneal cavity
- location of anastomosis, stoma (small bowel or colon), quality of anastomosis
- risk for bleeding
- type of closure (mesh, fascial, open abdomen, etc...)
- when to start oral diet / enteral feeding
Sentinel node and PET for local advanced breast cancer
To validate sentinel node biopsy (SLN) for patients with complete axillary response to preoperative chemotherapy
Advanced breast cancer & chemo by me
This document summarizes the presentation of Dr. Sadia Sadiq on locally advanced breast cancer and chemotherapy. The presentation covers staging of breast cancer, local surgical treatments, management of the axilla, adjuvant and neoadjuvant chemotherapy. It discusses the evolution of surgical treatments from radical mastectomy to breast-conserving surgery plus radiation. It also summarizes landmark trials comparing different chemotherapy regimens and the addition of taxanes to anthracycline-based regimens. Finally, it notes that sequential therapy with anthracyclines/alkylators followed by taxanes was proven superior to concurrent taxane-anthracycline-alkylator treatments.
Early breast cancer management
This document discusses the management of early breast cancer. It covers breast management including breast-conserving surgery and mastectomy. It discusses axillary management including axillary lymph node dissection and sentinel lymph node biopsy. It also discusses the roles of pre-operative systemic therapy, adjuvant therapy including anti-HER2 therapy, chemotherapy, and hormonal therapy based on breast cancer subtypes. The document provides guidelines on treatment options based on breast cancer stage and molecular profiles.
Early Stage Breast Cancer and Radiation Therapy
These slides are intended as an educational overview for newly diagnosed early stage breast cancer patients. My hope is that it can complement and enhance the doctor-patient relationship and shared decision making. I welcome any feedback on how to improve it.
Radiotherapy breast
The document discusses breast-conserving treatment for early-stage breast cancer. Breast-conserving treatment, including wide local excision of the tumor, axillary lymph node dissection, and breast irradiation, is now the standard of care for most women with early-stage invasive breast cancer. Ideal candidates for breast-conserving treatment have unicentric primary tumors less than 4-5 cm in diameter. Contraindications include positive margins, advanced or multicentric disease, pregnancy, and prior radiation. The addition of a radiation boost to the tumor bed after whole breast irradiation reduces the risk of local recurrence. Hypofractionated regimens have been shown to be as effective as conventional fractionation with shorter treatment times.
Efruzhu cancer carcinogenesis theory20
Decreasing energy levels in cells can cause an increase in mutations, leading to higher malignancy and aggressiveness of cancer. Lower energy levels may promote more mutations that drive carcinogenesis. Cells with decreased energy and more mutations are likely to become more malignant tumors.
Efruzhu cancer carci̇nogenesi̇s theory20
This document discusses a theory that decreasing energy levels or degrees within cells can cause an increase in mutations, leading to higher levels of malignancy and aggressiveness in cancer. Specifically, the theory proposes that as energy decreases within cells, mutation rates rise, resulting in more malignant and aggressive forms of cancer.
Locally advanced breast cancer
This document discusses the management of locally advanced breast cancer (LABC). Key points:
1. LABC includes stages IIIA, IIIB, IIIC breast cancer with large tumors (>5cm), chest wall involvement, skin ulcers, or fixed lymph nodes. Inflammatory breast cancer is an aggressive subtype of LABC.
2. Diagnosis involves history, physical exam, imaging like mammography and MRI, and biopsy. Staging workup includes labs, imaging of chest, abdomen, pelvis and bone.
3. Treatment involves neoadjuvant chemotherapy to downstage the cancer and allow for surgery. Surgery may include mastectomy or breast conservation. Postoperative radiation and endocrine therapy
MCO 2011 - Slide 8 - E. Senkus-Konefka - Treatment of metastatic disease and ...
MCO 2011 - Slide 8 - E. Senkus-Konefka - Treatment of metastatic disease and ...European School of Oncology
(1) Neoadjuvant therapy for breast cancer can improve operability and allow for breast-conserving surgery, though some studies have found higher recurrence rates in patients who undergo less aggressive local therapy after tumor shrinkage from neoadjuvant treatment.
(2) The NOAH study found that adding trastuzumab to neoadjuvant chemotherapy significantly improved pathological complete response rates and event-free survival in HER2-positive breast cancer compared to chemotherapy alone.
(3) Multiple studies have found a survival benefit for surgery in selected metastatic breast cancer patients, such as those with a solitary metastasis or intact primary tumor, suggesting a more aggressive multidisciplinary approach may be warranted in these cases.BALKAN MCO 2011 - E. Vrdoljak - Locoregional therapy in LABC
The document discusses evidence from randomized controlled trials on the use of postmastectomy radiotherapy (PMRT) for breast cancer patients. The key trials found that PMRT reduces locoregional recurrence rates from 30% to 10% and breast cancer mortality by 5% at 15 years. PMRT improved disease-free and overall survival rates particularly in patients with 4 or more positive lymph nodes. Modern radiotherapy techniques can help reduce risks of complications from PMRT.
BALKAN MCO 2011 - A. Eniu - How to optimize systemic therapy in LABC
This document discusses treatment options for locally advanced breast cancer (LABC). It notes that LABC is a heterogeneous disease and standard primary chemotherapy includes anthracyclines and taxanes. Neoadjuvant chemotherapy is now the standard of care as it allows for breast conservation in some cases and those who achieve a pathological complete response have improved survival rates. The response to neoadjuvant therapy and molecular subtypes (e.g. triple negative, HER2-positive) can help determine the most effective adjuvant treatment strategy. Targeted therapies like trastuzumab improve outcomes for HER2-positive breast cancer when given with chemotherapy in the neoadjuvant setting.
What's hot (14)
Primary Systemic Therapy for Inflammatory Breast Cancer
Primary Systemic Therapy for Inflammatory Breast Cancer
Surgeon-Anaesthetist-Intensivist Crosstalk In Abdominal Emergencies (Zsolt Bo...
Surgeon-Anaesthetist-Intensivist Crosstalk In Abdominal Emergencies (Zsolt Bo...
Sentinel node and PET for local advanced breast cancer
Sentinel node and PET for local advanced breast cancer
MCO 2011 - Slide 8 - E. Senkus-Konefka - Treatment of metastatic disease and ...
MCO 2011 - Slide 8 - E. Senkus-Konefka - Treatment of metastatic disease and ...
BALKAN MCO 2011 - E. Vrdoljak - Locoregional therapy in LABC
BALKAN MCO 2011 - E. Vrdoljak - Locoregional therapy in LABC
BALKAN MCO 2011 - A. Eniu - How to optimize systemic therapy in LABC
BALKAN MCO 2011 - A. Eniu - How to optimize systemic therapy in LABC
Viewers also liked
Artículo sobre la mejora del hábitat del oso pardo en el Alto Sil de León
La población de oso pardo en la Cordillera Cantábrica se ha multiplicado por tres en los últimos quince años, con alrededor de 180 osos en la subpoblación occidental y 30 en la oriental. Aunque la recuperación de la subpoblación oriental ha sido más lenta, se cree que el proceso es ahora imparable. La Fundación Banco Santander plantará 18.000 frutales en zonas mineras de León para proporcionar refugio y alimento a los osos y ayudar a unir las dos subpoblaciones.
1 pager of on demand resources
This document provides a list of useful resources for Connect hosts, including quick start guides, user manuals, daily online training, on-demand video tutorials, resource centers, user forums, webinars, downloads, and information on custom apps and extensions.
Untitled Presentation
The document is a Haiku Deck presentation that contains photos credited to four different photographers and encourages the viewer to create their own Haiku Deck presentation on SlideShare.
#BMO15 | Altrove | Niccolò Falsetti
#Altrove (www.altrove.me) è un esperimento che si presenta sotto forma di gioco urbano. I protagonisti, i giocatori, sono dieci ragazzi che attraversano la città e il web non come luoghi da cui fuggire ma come situazioni da esplorare. Lo ha raccontato come un “real life-social network”. Niccolò Falsetti (nato a Grosseto classe 1987) è uno degli ideatori del progetto Altrove.
Cronica tita
El documento describe el programa TIT@ Educación Digital para Todos implementado por el Ministerio de Educación y la Universidad del Valle en Colombia. El programa busca capacitar maestros en el uso de las TIC en la enseñanza mediante cinco momentos que incluyen contextualización, adaptación, adopción, apropiación y transformación del aprendizaje. La autora del documento detalla su experiencia participando en el programa, en el que ha adquirido nuevas habilidades y herramientas que le han permitido enriquecer su práctica docente.
Daryeli Romero
Internet es una red mundial de computadoras que permite el intercambio de información. Surgió en 1969 como un proyecto militar estadounidense llamado ARPANET y ha revolucionado la comunicación global. Internet ofrece diversos servicios como correo electrónico, navegación web, chat y redes sociales. Para acceder a Internet se necesita una computadora, un módem, una conexión física como una línea telefónica y un contrato con un proveedor de servicios de Internet.
Q2
This document summarizes how a media product represents teenagers. It focuses on a magazine created by the author for a teenage audience. On the front cover are three teenage models - the main feature is a 17-year-old singer, Oceana, dressed casually in a band t-shirt and jeans to appear like a typical teenager. The writing aims to be neither too formal nor informal so as not to patronize the intended 13+ audience. Images of Oceana are welcoming and non-intimidating to connect with teenage readers, and the interview is in a simple question-answer format for easy reading. The target audience of teenagers is represented through focusing on an artist who lives a normal teenage life attending college.
Viewers also liked (10)
Artículo sobre la mejora del hábitat del oso pardo en el Alto Sil de León
Artículo sobre la mejora del hábitat del oso pardo en el Alto Sil de León
More from PHİLOSOPHER EFRUZHU PHRMP
New holy collision 999999999
1. APEX DEGREE MEDICAL PHILOSOPHER EFRUZHU1 PHRMP "HOLY COLLISION" THEORYEM NCY. TCY ®© INSTEAD OF BIG BANG THEORY
https://essafihucancertrea.wixsite.com/universalspaceallahu …
https://www.flickr.com/photos/efruzhucancerfinished/ …
THE BIG BANG THEORY AND THE EVOLUTIONARY THEORY THE END COMPLETELY FINISHED
New holy collision 99999999
1. APEX DEGREE MEDICAL PHILOSOPHER EFRUZHU1 PHRMP "HOLY COLLISION" THEORYEM NCY. TCY ®© INSTEAD OF BIG BANG THEORY
https://essafihucancertrea.wixsite.com/universalspaceallahu …
https://www.flickr.com/photos/efruzhucancerfinished/ …
THE BIG BANG THEORY AND THE EVOLUTIONARY THEORY THE END COMPLETELY FINISHED
New holy collision 9999999
1. APEX DEGREE MEDICAL PHILOSOPHER EFRUZHU1 PHRMP "HOLY COLLISION" THEORYEM NCY. TCY ®© INSTEAD OF BIG BANG THEORY
https://essafihucancertrea.wixsite.com/universalspaceallahu …
https://www.flickr.com/photos/efruzhucancerfinished/ …
THE BIG BANG THEORY AND THE EVOLUTIONARY THEORY THE END COMPLETELY FINISHED
New holy collision 999999
1. APEX DEGREE MEDICAL PHILOSOPHER EFRUZHU1 PHRMP "HOLY COLLISION" THEORYEM NCY. TCY ®© INSTEAD OF BIG BANG THEORY
https://essafihucancertrea.wixsite.com/universalspaceallahu …
https://www.flickr.com/photos/efruzhucancerfinished/ …
THE BIG BANG THEORY AND THE EVOLUTIONARY THEORY THE END COMPLETELY FINISHED
New holy collision 99999
1. APEX DEGREE MEDICAL PHILOSOPHER EFRUZHU1 PHRMP "HOLY COLLISION" THEORYEM NCY. TCY ®© INSTEAD OF BIG BANG THEORY
https://essafihucancertrea.wixsite.com/universalspaceallahu …
https://www.flickr.com/photos/efruzhucancerfinished/ …
THE BIG BANG THEORY AND THE EVOLUTIONARY THEORY THE END COMPLETELY FINISHED
New holy collision 9999
1. APEX DEGREE MEDICAL PHILOSOPHER EFRUZHU1 PHRMP "HOLY COLLISION" THEORYEM NCY. TCY ®© INSTEAD OF BIG BANG THEORY
https://essafihucancertrea.wixsite.com/universalspaceallahu …
https://www.flickr.com/photos/efruzhucancerfinished/ …
THE BIG BANG THEORY AND THE EVOLUTIONARY THEORY THE END COMPLETELY FINISHED
New holy collision 999
1. APEX DEGREE MEDICAL PHILOSOPHER EFRUZHU1 PHRMP "HOLY COLLISION" THEORYEM NCY. TCY ®© INSTEAD OF BIG BANG THEORY
https://essafihucancertrea.wixsite.com/universalspaceallahu …
https://www.flickr.com/photos/efruzhucancerfinished/ …
THE BIG BANG THEORY AND THE EVOLUTIONARY THEORY THE END COMPLETELY FINISHED
More from PHİLOSOPHER EFRUZHU PHRMP (20)
Hu cancer treatment theory and laws 5
- 1. . BY EFRUZ ASİLOĞLU CARCİNOGENESİS&GLOBAL&UNİVERSAL&BALANCED CANCER TREATMENT THEORETİCİAN